Everolimus 10 mg Clinical Trials

3 actively recruiting trials

Also known as: Afinitor, CapOx/GemOx

Pipeline

Phase 2: 1Phase 1/2: 1Phase 2/3: 1

Top Sponsors

Fudan University1
Forward Pharmaceuticals Co., Ltd.1
Banaras Hindu University1

Indications

Cancer3
Breast Cancer2
Locally Advanced Breast Cancer (LABC)1
ER+ Breast Cancer1
Breast Cancer Stage II1

Other3 trials

A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC

Phase 1/2

Addition of Everolimus to Standard of Care in Carcinoma Gallbladder

Phase 2/3

Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.